Showing results (21-30 of 541) with videos related to
Sort By:
Pageof 55
Clinical Pharmacology and Therapeutics|April 1, 1981
Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylationT P Sloan, J R Idle, R L SmithJournal of Chromatography|March 4, 1988
Determination of nifedipine and its three principal metabolites in plasma and urine by automated electron-capture capillary gas chromatographyB J Schmid, H E Perry, J R IdleXenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1980
The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationS I Islam, J R Idle, R L SmithFood and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 31, 1997
A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarinH Hadidi, K Zahlsen, J R Idle, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1982
The metabolism of [14C]cimetidine in manS C Mitchell, J R Idle, R L SmithCancer Research|September 15, 1988
Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patientsA H Hadidi, C E Coulter, J R IdleThe Journal of Pharmacy and Pharmacology|March 1, 1981
Animal modelling of human polymorphic drug oxidation--the metabolism of debrisoquine and phenacetin in rat inbred strainsS G Al-Dabbagh, J R Idle, R L SmithPharmacogenetics|April 1, 1994
The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European populationM Armstrong, K Fairbrother, J R Idle, et al.Environmental Health Perspectives|November 1, 1994
Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibilityA K Daly, S Cholerton, M Armstrong, et al.Pharmacology & Therapeutics|February 1, 1993
Metabolic polymorphismsA K Daly, S Cholerton, W Gregory, et al.Pageof 55